Edition:
United States

Medifast Inc (MED)

MED on New York Consolidated

67.03USD
17 Nov 2017
Change (% chg)

$2.06 (+3.17%)
Prev Close
$64.97
Open
$64.86
Day's High
$67.40
Day's Low
$64.86
Volume
375,607
Avg. Vol
119,257
52-wk High
$71.73
52-wk Low
$38.43

Latest Key Developments (Source: Significant Developments)

Medifast posts Q3 earnings per share $0.55
Tuesday, 7 Nov 2017 04:05pm EST 

Nov 7 (Reuters) - Medifast Inc :Sees q4 earnings per share $0.46 to $0.49.Q3 earnings per share $0.55.Sees Q4 revenue $71.4 million to $74.4 million.Q3 revenue $77.2 million.Cash, cash equivalents, investment securities rose $18.9 million to $95.7 million as of Sept. 30,2017 compared to $76.8 million at Dec. 31,2016​.  Full Article

Medifast Q2 earnings per share $0.63
Tuesday, 8 Aug 2017 04:05pm EDT 

Aug 8 (Reuters) - Medifast Inc :Medifast Inc announces second quarter 2017 financial results.Sees Q3 earnings per share $0.48 to $0.51 from continuing operations.Q2 earnings per share $0.63.Sees Q3 revenue $72 million to $75 million.Reaffirms FY 2017 earnings per share view $2.05 to $2.15.Sees FY 2017 revenue $290 million to $300 million.Q2 revenue $75.7 million.  Full Article

Medifast posts Q2 earnings per share $0.63
Tuesday, 8 Aug 2017 04:05pm EDT 

Aug 8 (Reuters) - Medifast Inc ::Medifast Inc announces second quarter 2017 financial results.Raises FY 2017 earnings per share view $2.05 to $2.15.Sees Q3 earnings per share $0.48 to $0.51 from continuing operations.Q2 earnings per share $0.63.Sees Q3 revenue $72 million to $75 million.Sees FY 2017 revenue $290 million to $300 million.Q2 revenue $75.7 million.  Full Article

Medifast Q1 earnings per share $0.51
Thursday, 4 May 2017 04:05pm EDT 

May 4 (Reuters) - Medifast Inc :Medifast, Inc. announces first quarter 2017 financial results.Q1 earnings per share $0.51.Reaffirms FY 2017 earnings per share view $2.00 to $2.10.Sees FY 2017 revenue $290 million to $300 million.Sees Q2 revenue $72 million to $75 million.Sees Q2 earnings per share $0.51 to $0.54 from continuing operations.Medifast inc says for Q1 of 2017, medifast revenue decreased 2.4% to $70.6 million from revenue of $72.3 million in q1 of 2016.  Full Article

Medifast Q4 earnings per share $0.34 from continuing operations
Thursday, 9 Mar 2017 04:05pm EST 

Medifast Inc : Medifast Inc. Announces fourth quarter and full year 2016 financial results . Sees Q1 earnings per share $0.45 to $0.48 from continuing operations . Q4 earnings per share $0.34 from continuing operations . Sees Q1 revenue $69 million to $73 million . Sees FY 2017 earnings per share $2.00 to $2.10 from continuing operations . Sees FY 2017 revenue $290 million to $300 million .Medifast Inc - for Q4, Medifast net revenue from continuing operations increased 2% to $62.5 million.  Full Article

Medifast reports 28 percent increase in quarterly dividend
Thursday, 8 Dec 2016 04:31pm EST 

Medifast Inc : Medifast Inc - has declared a $0.32 quarterly cash .Sets quarterly cash dividend of $0.32 per share.  Full Article

Medifast announces third quarter 2016 financial results
Thursday, 3 Nov 2016 04:05pm EDT 

Medifast Inc : Qtrly revenue $68.6 million versus $65.9 million . Medifast, Inc. announces third quarter 2016 financial results . Sees Q4 2016 earnings per share $0.30 to $0.33 from continuing operations . Q3 earnings per share $0.51 from continuing operations . Sees q4 2016 revenue about $63 million to $66 million . Raises fy 2016 adjusted earnings per share view to $1.86 to $1.89 from continuing operations . Sees fy 2016 earnings per share $1.45 to $1.48 from continuing operations .Sees fy 2016 revenue $275 million to $278 million.  Full Article

Medifast announces appointment of Daniel Chard as CEO
Monday, 3 Oct 2016 05:05pm EDT 

Medifast Inc : Chard succeeds michael macdonald, who will stay with medifast in role of executive chairman of board . Chard has been appointed as a member of medifast's board of directors, effective today, bringing size of board to 10 members . Medifast, inc. Announces appointment of direct selling industry veteran daniel r. Chard as chief executive officer . Says expects to meet or exceed q3 guidance for revenue from continuing operations in range of approximately $64.0 million to $67.0 million .Expects to meet or exceed q3 guidance for earnings per diluted share from continuing operations in range of $0.43 to $0.46 per diluted share.  Full Article

Medifast raises FY adjusted earnings from cont ops forecast
Wednesday, 3 Aug 2016 04:05pm EDT 

Medifast Inc : Medifast, inc. Announces second quarter 2016 financial results . Q2 adjusted earnings per share $0.63 from continuing operations . Sees q3 2016 revenue about $64 million to $67 million . Q2 revenue $71.1 million . Sees q3 2016 earnings per share $0.43 to $0.46 from continuing operations . Q2 earnings per share $0.29 from continuing operations . Sees fy 2016 revenue $275 million to $282 million . Says company reiterated its fy guidance for revenue from continuing operations . Says is raising its fy guidance for adjusted earnings per diluted share from continuing operations to $1.79 to $1.84 . Fy 2016 earnings per diluted share from continuing operations is now expected to be in range of $1.38 to $1.43 . Says company expects q3 2016 revenue from continuing operations to be in range of approximately $64.0 million to $67.0 million .Says fy earnings per diluted share from continuing operations is now expected to be in range of $1.38 to $1.43.  Full Article

Medifast Inc Raises FY 2016 guidance; gives Q2 2016 guidance
Wednesday, 4 May 2016 04:05pm EDT 

Medifast Inc:Expects Q2 2016 net revenue from continuing operations to be in the range of approximately $70.0 million to $73.0 million and adjusted earnings per diluted share from continuing operations in the range of $0.50 to $0.53 per diluted share.Raised FY 2016 guidance for revenue from continuing operations to be in the range of $275.0 million to $282.0 million and adjusted earnings per diluted share from continuing operations in the range of $1.75 to $1.80 per diluted share.  Full Article

BRIEF-Medifast posts Q3 earnings per share $0.55

* Cash, cash equivalents, investment securities rose $18.9 million to $95.7 million as of Sept. 30,2017 compared to $76.8 million at Dec. 31,2016​ Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1 646 223 8780)